ACNS-BC - Clinical Specialist in Medical Surgical Nursing

Dr. Schneider is Associate Professor and serves as faculty lead for the graduate oncology specialty at the School of Nursing. She received her doctorate in nursing from Case Western Reserve University, her Master of Science degree from Texas Woman’s University, and her BSN from the University of Akron. Dr. Schneider has extensive experience in pediatric and adult oncology nursing. She holds certification as a clinical nurse specialist and as an advanced oncology certified nurse.
Prior to joining the faculty at Duke University, Dr. Schneider taught in the oncology program at Frances Payne Bolton School of Nursing at Case Western Reserve University, and was a clinical nurse specialist at University Hospitals of Cleveland. She is professionally active in a number of nursing organizations. She has chaired the American Cancer Society Peer Review Committee on Scholarships and Professorships in Oncology Nursing, served as a member of the Oncology Nursing Society (ONS) national board of directors, and is now President-Elect of the ONS. Dr. Schneider has received both the Excellence in Cancer Nursing Research and Excellence in Cancer Nursing Education Awards from the Oncology Nursing Society and is a Fellow of the American Academy of Nursing.
Dr. Schneider's research interests include management of symptom distress in cancer patients, the use of distraction interventions to enhance coping, and the use of tailored protocols to promote chemotherapy adherence.

Research Interests:

Dr. Schneider’s research interests include the management of symptom distress in cancer patients and the use of distraction interventions to enhance coping. She has conducted a series of four studies exploring the use of a virtual reality distraction intervention to mitigate chemotherapy related symptom distress in adult and pediatric populations.
Current research includes a randomized clinical trial of a tailored intervention protocol designed to promote adherence to oral chemotherapy in adults receiving treatment for breast or colorectal cancer.